Ifosfamide‐induced encephalopathy: Brand‐name (HOLOXAN®) vs generic formulation (IFOSFAMIDE EG®)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ifosfamide‐induced encephalopathy: Brand‐name (HOLOXAN®) vs generic formulation (IFOSFAMIDE EG®)

Published:2019-03-04 Issue:3 Volume:44 Page:372-380
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Chambord Jeremy¹,Henny Fabien¹,Salleron Julia²,Hombourger Benoit¹,Lider Pauline³,Vigneron Jean³,Demore Beatrice³⁴,Vallance Catherine¹,Rios Maria⁵

Affiliation:

1. Department of Pharmacy Institut de Cancérologie de Lorraine (ICL) Vandœuvre‐lès‐Nancy France

2. Data Biostatistics Unit Institut de Cancérologie de Lorraine (ICL) Vandœuvre‐lès‐Nancy France

3. Department of Pharmacy Centre hospitalier régional universitaire (CHRU) Vandœuvre‐lès‐Nancy France

4. EA 4360 Apemac Université de Lorraine Nancy France

5. Department of Medical Oncology Institut de Cancérologie de Lorraine (ICL) Vandœuvre‐lès‐Nancy France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.12823

Reference32 articles.

1. Clinical Pharmacokinetics and Pharmacodynamics of Ifosfamide and its Metabolites

2. Ifosfamide: pharmacokinetic properties for central nervous system metastasis prevention

3. The Neurotoxicity and Pharmacokinetics of Oral Ifosfamide

4. Ifosfamide encephalopathy associated with chemotherapy for musculoskeletal sarcomas: incidence, severity, and risk factors

5. Ifosfamide associated myoclonus-encephalopathy syndrome

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generic substitution of amlodipine is not associated with increased risk of mortality or adverse cardiovascular events: An observational cohort study;Clinical and Translational Science;2024-03-28

2. Switch to generic formulation of temozolomide results in statistically significant increase in grade 3 and 4 bone marrow toxicity in glioma patients in the province of Alberta;Neuro-Oncology Practice;2023-10-27

3. Aprepitant, fosaprepitant and risk of ifosfamide-induced neurotoxicity: a systematic review;Cancer Chemotherapy and Pharmacology;2022-05-30

4. Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-1506-STBSG “ANITA”;European Journal of Cancer;2021-07

5. Incidence of ifosfamide induced encephalopathy in patients receiving concomitant fosaprepitant;Journal of Oncology Pharmacy Practice;2020-11-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3